Harvard, affiliated bodies face probe over integrity

Harvard University and researchers at its affiliated medical institutions are facing multiple accusations about their academic integrity.

The investigation at Dana-Farber Cancer Institute, or DFCI, associated with Harvard Medical School and considered one of the top centers for cancer research and treatment in the United States, involves four of its senior cancer researchers and administrators.

Harvard Business School's professor Francesca Gino was put on administrative leave following claims that her work included falsified data.